欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号LV/H/0161/001
药品名称Avabrad 5 mg film-coated tablets
活性成分
    • IVABRADINE HYDROCHLORIDE 5.0 mg
剂型Film-coated tablet
上市许可持有人Medochemie Ltd. 1-10 Constantinoupoleos Street Limassol 3011 Cyprus
参考成员国 - 产品名称Latvia (LV)
Apredonav 5 mg apvalkotās tabletes
互认成员国 - 产品名称
    • Spain (ES)
    • Greece (GR)
    • Lithuania (LT)
      APREDONAV 5 mg plėvele dengtos tabletės
    • Bulgaria (BG)
      Avabrad
    • Cyprus (CY)
      Avabrad 5mg film coated tablets
    • Romania (RO)
      APREDONAV 5 mg comprimate filmate
    • Slovenia (SI)
      Apredonav 5 mg filmsko obložene tablete
    • Malta (MT)
      Avabrad 5 mg film-coated tablets
许可日期2018/12/27
最近更新日期2023/05/22
药物ATC编码
    • C01EB17 ivabradine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase